Showing results (751-760 of 1,231) with videos related to

Sort By:
Pageof 124
Vascular Health and Risk Management|August 24, 2010
Estimating glomerular filtration rate in a population-based studyAnoop Shankar, Kristine E Lee, Barbara E K Klein, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 4, 2024
GM-1020: a novel, orally bioavailable NMDA receptor antagonist with rapid and robust antidepressant-like effects at well-tolerated doses in rodentsAdam K Klein, Eric W Austin, Michael J Cunningham, et al.
Ophthalmology|June 10, 2008
Inflammation, complement factor h, and age-related macular degeneration: the Multi-ethnic Study of AtherosclerosisRonald Klein, Michael D Knudtson, Barbara E K Klein, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 5, 2018
Multicenter Phase II Study of Sequential Brentuximab Vedotin and Doxorubicin, Vinblastine, and Dacarbazine Chemotherapy for Older Patients With Untreated Classical Hodgkin LymphomaAndrew M Evens, Ranjana H Advani, Irene B Helenowski, et al.
Cardiovascular Research|October 3, 2003
Infections and endothelial cellsTymen T Keller, Albert T A Mairuhu, Martijn D de Kruif, et al.
Virology|April 1, 1995
Rat monoclonal antibodies differentiating between the Epstein-Barr virus nuclear antigens 2A (EBNA2A) and 2B (EBNA2B)E Kremmer, B R Kranz, A Hille, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 29, 2011
Bidirectional association of retinal vessel diameters and estimated GFR decline: the Beaver Dam CKD StudyCharumathi Sabanayagam, Anoop Shankar, Barbara E K Klein, et al.
American Journal of Human Genetics|December 24, 2003
Dissection of genomewide-scan data in extended families reveals a major locus and oligogenic susceptibility for age-related macular degenerationSudha K Iyengar, Danhong Song, Barbara E K Klein, et al.
Kidney International|August 26, 2011
Markers of inflammation predict the long-term risk of developing chronic kidney disease: a population-based cohort studyAnoop Shankar, Liping Sun, Barbara E K Klein, et al.
Experimental Hematology & Oncology|October 26, 2018
Daratumumab binds to mobilized CD34+ cells of myeloma patients in vitro without cytotoxicity or impaired progenitor cell growthXun Ma, Sandy W Wong, Ping Zhou, et al.
Pageof 124